Western Standard LLC’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Western Standard LLC’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-482,874	Closed	-$874K	–	41
2023 Q2	$874K	Buy	+482,874	New	+$883K	0.75%	23

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Western Standard LLC's PRDS Position: Q3 2023 in Review

Western Standard LLC sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 482,874 shares — an estimated $874K sold.

Western Standard LLC first reported a position in PRDS in Q2 2023 and held it in 1 quarter. The position peaked at $874K in Q2 2023. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

Western Standard LLC reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Western Standard LLC sold 482,874 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $874K.
Western Standard LLC first reported a position in Pardes Biosciences, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Western Standard LLC's Pardes Biosciences, Inc. Common Stock position peaked at $874K in Q2 2023.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Western Standard LLC's 13F filing for Q3 2023, filed 14 Nov 2023.